Cyclomics
Cyclomics is a Dutch biotech company specializing in advanced molecular diagnostics and DNA sequencing for cancer detection and monitoring. They utilize cutting-edge technologies like Nanopore sequencing, proprietary molecular assays, and AI to analyze circulating tumor DNA from liquid biopsies. Their innovative approach focuses on real-time, non-invasive cancer detection, providing insights into tumor dynamics and treatment efficacy. Key products include CyclomicsSeq for ultra-accurate sequencing, MeCy for methylation analysis without bisulfite treatment, and PlasmidSeq for high-resolution plasmid sequencing. Cyclomics offers tailored Contract Research Organization (CRO) services and collaborates with research institutions and healthcare providers to accelerate research and improve patient outcomes.
Cyclomics
Cyclomics is a Dutch biotech company specializing in advanced molecular diagnostics and DNA sequencing for cancer detection and monitoring. They utilize cutting-edge technologies like Nanopore sequencing, proprietary molecular assays, and AI to analyze circulating tumor DNA from liquid biopsies. Their innovative approach focuses on real-time, non-invasive cancer detection, providing insights into tumor dynamics and treatment efficacy. Key products include CyclomicsSeq for ultra-accurate sequencing, MeCy for methylation analysis without bisulfite treatment, and PlasmidSeq for high-resolution plasmid sequencing. Cyclomics offers tailored Contract Research Organization (CRO) services and collaborates with research institutions and healthcare providers to accelerate research and improve patient outcomes.